Holding La Pharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €115k and a net result of €15k. Its solvency ranks better than 13% of 5498 sector peers (fiscal year 2025). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit advice for your own amount and term
Signals
Three signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years, statistically higher risk.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 07-07-2026, 24 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
24 d early
← before the deadline
after the deadline →
Financials · fiscal year 2025, abbreviated schema
Equity
€115k
Total assets
€1.15M
Net result
€15k
Working capital
€-201k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Balance-sheet composition
Assets €1.15M
Fixed assets
€1.01M
Current assets
€136k
Equity and liabilities €1.15M
Equity
€115k
Debt
€1.03M
Debt finances 89.9% of the balance-sheet total.
Key figures and ratios
Solvency
10.1%
ROE
13.1%
ROA
1.3%
Debt
€1.03M
Debt ≤ 1 year
€337k
Debt > 1 year
€679k
Income taxes
€6k
Staff costs
€194k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet
Code2025
Assets
Total assets20/58€1.15M
Fixed assets21/28€1.01M
Financial fixed assets28€1.01M
Current assets29/58€136k
Amounts receivable within one year40/41€129k
Trade receivables40€129k
Cash at bank and in hand54/58€5k
Deferred charges and accrued income490/1€2k
Equity and liabilities
Total equity and liabilities10/49€1.15M
Equity10/15€115k
Contributions10/11€100k
Reserves13€15k
Distributable reserves133€15k
Amounts payable17/49€1.03M
Amounts payable after more than one year17€679k
Financial debts170/4€679k
Amounts payable within one year42/48€337k
Current portion of amounts payable after more than one year42€70k
Trade debts44€92k
Suppliers440/4€92k
Taxes, remuneration and social security45€77k
Taxes450/3€52k
Remuneration and social security454/9€26k
Other amounts payable47/48€98k
Accrued charges and deferred income492/3€14k
Income statement
Code2025
Remuneration, social security and pensions62€194k
Other operating charges640/8€450
Gross operating margin9900€258k
Operating profit (loss)9901€63k
Financial income75/76B€217
Recurring financial income75€217
Financial charges65/66B€42k
Recurring financial charges65€42k
Profit (loss) for the period before taxes9903€21k
Income taxes67/77€6k
Profit (loss) for the period9904€15k
Profit (loss) for the period to be appropriated9905€15k
Appropriation of the result
Profit (loss) to be appropriated9906€15k
Transfer to equity691/2€15k
To other reserves6921€15k
Social balance
Average headcount (FTE)90871.9
The notes to these accounts (12 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2026
07-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
NBB filing
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Beveren-Kruibeke-Zwijndrecht · 1 establishment unit since 2025
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Geeraard de Cremerstraat 129150 Beveren-Kruibeke-ZwijndrechtGround area
623 m²
Building footprint
288 m²
Volume, LiDAR
1,955 m³
Parcel 46018A0090/00F000, Flanders · tallest building 13.2 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Holding La Pharma
since 20252.371.345.241
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 46018A0090/00F000 | Flanders | 623 m² | 1 · 288 m² | 13.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
PHARMACIE JUPSIN
BE 0463.794.711
Hotton · Eq €115k
PHARMAHEALTH
BE 0423.649.181
Zottegem · Eq €115k
PHARMARIVE
BE 0521.688.764
Etterbeek · Eq €115k
FELIS PHARMA
BE 0795.546.983
Oosterzele · Eq €115k
CLAIVER
BE 0863.396.307
Heuvelland · Eq €115k
Of 5,224 companies in sector 47730 we hold annual accounts for 3,864. 3,484 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded18-03-2025
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
64210Activities of holding companies
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers
Data from official sources, last processed on 15-09-2026. Scores and ratios are computed by Checked and are not a credit decision.